Recombinant adeno-associated virus (rAAV) vectors based on AAV type 2 can safely transduce various tissues and result in persistent gene expression in vivo 1,2,3,4,5,6,7. Therapeutic levels of human ...

Chicago, Aug. 25, 2025 (GLOBE NEWSWIRE) -- The global viral vectors & plasmid DNA manufacturing market was valued at US$ 4.21 billion in 2024 and is expected to reach US$ 20.30 billion by 2033, ...